AUPH earnings: a positive outcome, +9.1%

On February 28, 2023, Aurinia Pharmaceuticals Inc. reached its earnings. The result was a positive outcome, and the stock moved +9.1% in the window around the event. It had already run -12.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.